Get the truth about GLP-1 weight loss drugs (Ozempic, Wegovy, etc.) from a doctor

The Health Continuum

Dr. Karen Radley discussesGLP-1 drugs, theirĀ  risks,and the importance of understanding the side effects and the long-term implications of using these medications, while also highlighting alternatives to weight loss.

Takeaways

GLP-1 drugs are primarily used for diabetes and obesity.

They stimulate insulin production and reduce appetite.

Patients with a BMI over 30 or comorbidities may benefit most.

Side effects include gastrointestinal issues and potential long-term risks.

Many patients stop using GLP-1 drugs due to side effects.

Weight regain is common after discontinuation of GLP-1 medications.

Diet and exercise remain crucial for sustainable weight loss.

Accountability in weight management programs enhances success.

Societal factors contribute to the obesity crisis, including diet change

@thehealthcontinuum.com

@weightlossdrugs

@ozempic

@wegovy

@GLP-1

2025-12-01 22 min

Available Results

Generated results are saved to the knowledge database for reuse and search.

No generated results are available for this episode yet.

Extract Knowledge

Pick what you want extracted first. Model, scope, and chapter options appear after a template is selected.

Generated results for public episodes are saved to the knowledge database so they can be reused and searched later.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.